HCA Healthcare (HCA) Stock Forecast & Price Target

Compare

1,673 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HCA Analyst Ratings

Moderate Buy

8 Buy

5 Hold

0 Sell

Based on 13 analysts giving stock ratings to

HCA

Healthcare

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HCA Stock 12 Month Forecast

Average Price Target

$392.18

▲(3.40%Upside)

Based on 13 Wall Street analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is $392.18 with a high forecast of $444.00 and a low forecast of $336.00. The average price target represents a 3.40% change from the last price of $379.30.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"297":"$297","334":"$334","371":"$371","408":"$408","445":"$445"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":444,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$444.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":392.18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$392.18</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":336,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$336.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[297,334,371,408,445],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,381.42,386.2338461538462,391.04769230769233,395.8615384615385,400.67538461538464,405.4892307692308,410.3030769230769,415.11692307692306,419.9307692307692,424.7446153846154,429.55846153846153,434.3723076923077,439.18615384615384,{"y":444,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,381.42,382.2476923076923,383.0753846153846,383.9030769230769,384.7307692307692,385.55846153846153,386.38615384615383,387.2138461538462,388.0415384615385,388.8692307692308,389.6969230769231,390.5246153846154,391.3523076923077,{"y":392.18,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,381.42,377.92615384615385,374.4323076923077,370.9384615384615,367.4446153846154,363.95076923076925,360.4569230769231,356.9630769230769,353.46923076923076,349.9753846153846,346.48153846153843,342.9876923076923,339.49384615384616,{"y":336,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":336.39,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":312.61,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":360.23,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":392.44,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":402.9,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":354.94,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":325.57,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":298.89,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":328.53,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":305.02,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":345.06,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":342.37,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":381.42,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$444.00

Average Price Target$392.18

Lowest Price Target$336.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$434

Buy

14.42%

Upside

Reiterated

06/07/25

HCA Healthcare's strong financial performance and positive technical indicators drive a high score. Robust earnings growth and effective cost management highlight operational strength, despite concerns over leverage and valuation constraints.

Ben HendrixRBC Capital

RBC Capital

$376→$404

Buy

6.51%

Upside

Reiterated

06/23/25

HCA Healthcare price target raised to $404 from $376 at RBC CapitalHCA Healthcare price target raised to $404 from $376 at RBC Capital

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$444

Buy

17.06%

Upside

Reiterated

06/17/25

Cantor Fitzgerald Sticks to Their Buy Rating for HCA Healthcare (HCA)

Lance WilkesBernstein

Bernstein

$378

Hold

-0.34%

Downside

Reiterated

06/17/25

HCA Healthcare (HCA) Gets a Hold from Bernstein

Craig HettenbachMorgan Stanley

Morgan Stanley

$355→$410

Hold

8.09%

Upside

Reiterated

06/09/25

Morgan Stanley Reaffirms Their Hold Rating on HCA Healthcare (HCA)

Whit MayoLeerink Partners

Leerink Partners

$390→$420

Buy

10.73%

Upside

Reiterated

06/04/25

Leerink Partners Sticks to Its Buy Rating for HCA Healthcare (HCA)

Andrew Mok CFABarclays

Barclays

$366→$416

Buy

9.68%

Upside

Reiterated

06/03/25

HCA Healthcare price target raised to $416 from $366 at BarclaysHCA Healthcare price target raised to $416 from $366 at Barclays

Stephen BaxterWells Fargo

Wells Fargo

$320→$385

Hold

1.50%

Upside

Upgraded

05/29/25

Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV) and HCA Healthcare (NYSE: HCA)

Joanna GajukBank of America Securities

Bank of America Securities

―

Buy

―

Reiterated

05/19/25

Bank of America Securities Remains a Buy on HCA Healthcare (HCA)

David S MacdonaldTruist Financial

Truist Financial

$390

Buy

2.82%

Upside

Reiterated

04/28/25

Analysts Conflicted on These Healthcare Names: HCA Healthcare (NYSE: HCA), Edwards Lifesciences (NYSE: EW) and Gilead Sciences (NASDAQ: GILD)

Matthew Gillmor CFAKeyBanc

KeyBanc

$370

Buy

-2.45%

Downside

Reiterated

04/28/25

KeyBanc Keeps Their Buy Rating on HCA Healthcare (HCA)

Ryan LangstonTD Cowen

TD Cowen

$377→$361

Buy

-4.82%

Downside

Reiterated

04/28/25

HCA Healthcare: Strong Financial Performance and Strategic Initiatives Drive Buy Rating

Michael HaRobert W. Baird

Robert W. Baird

$396→$336

Hold

-11.42%

Downside

Downgraded

04/14/25

HCA Healthcare downgraded to Neutral from Outperform at BairdHCA Healthcare downgraded to Neutral from Outperform at Baird

Jason CassorlaGuggenheim

Guggenheim

―

Hold

―

Initiated

04/08/25

Guggenheim starts HCA Healthcare Inc (HCA) at NeutralGuggenheim analyst Jason Cassorla initiates coverage on HCA Healthcare Inc (NYSE: HCA) with a Neutral rating.

Ann HynesMizuho Securities

Mizuho Securities

$425

Buy

12.05%

Upside

Reiterated

02/27/25

Analysts Are Bullish on Top Healthcare Stocks: HCA Healthcare (HCA), Kura Oncology (KURA)We hosted a Fireside chat with HCA CFO Michael Marks. Key takeaways from our call include: 1) the outlook in Washington was a key investor focus, 2) HCA believes 2025 guidance fully captures all potential outcomes, 3) base underlying demand trends remain solid and pricing should continue to be strong in 2025, and 4) HCA’s strong balance sheet and cash flow continue to provide financial optionality going forward. We continue to believe earnings visibility remains high for 2025. We are reiterating our Outperform rating. Key Topic. The Washington outlook was a key focus given the potential for healthcare to be a pay-for in the upcoming tax reforms.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$434

Buy

14.42%

Upside

Reiterated

06/07/25

Ben HendrixRBC Capital

RBC Capital

$376→$404

Buy

6.51%

Upside

Reiterated

06/23/25

HCA Healthcare price target raised to $404 from $376 at RBC CapitalHCA Healthcare price target raised to $404 from $376 at RBC Capital

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$444

Buy

17.06%

Upside

Reiterated

06/17/25

Cantor Fitzgerald Sticks to Their Buy Rating for HCA Healthcare (HCA)

Lance WilkesBernstein

Bernstein

$378

Hold

-0.34%

Downside

Reiterated

06/17/25

HCA Healthcare (HCA) Gets a Hold from Bernstein

Craig HettenbachMorgan Stanley

Morgan Stanley

$355→$410

Hold

8.09%

Upside

Reiterated

06/09/25

Morgan Stanley Reaffirms Their Hold Rating on HCA Healthcare (HCA)

Whit MayoLeerink Partners

Leerink Partners

$390→$420

Buy

10.73%

Upside

Reiterated

06/04/25

Leerink Partners Sticks to Its Buy Rating for HCA Healthcare (HCA)

Andrew Mok CFABarclays

Barclays

$366→$416

Buy

9.68%

Upside

Reiterated

06/03/25

HCA Healthcare price target raised to $416 from $366 at BarclaysHCA Healthcare price target raised to $416 from $366 at Barclays

Stephen BaxterWells Fargo

Wells Fargo

$320→$385

Hold

1.50%

Upside

Upgraded

05/29/25

Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV) and HCA Healthcare (NYSE: HCA)

Joanna GajukBank of America Securities

Bank of America Securities

―

Buy

―

Reiterated

05/19/25

Bank of America Securities Remains a Buy on HCA Healthcare (HCA)

David S MacdonaldTruist Financial

Truist Financial

$390

Buy

2.82%

Upside

Reiterated

04/28/25

Analysts Conflicted on These Healthcare Names: HCA Healthcare (NYSE: HCA), Edwards Lifesciences (NYSE: EW) and Gilead Sciences (NASDAQ: GILD)

Matthew Gillmor CFAKeyBanc

KeyBanc

$370

Buy

-2.45%

Downside

Reiterated

04/28/25

KeyBanc Keeps Their Buy Rating on HCA Healthcare (HCA)

Ryan LangstonTD Cowen

TD Cowen

$377→$361

Buy

-4.82%

Downside

Reiterated

04/28/25

HCA Healthcare: Strong Financial Performance and Strategic Initiatives Drive Buy Rating

Michael HaRobert W. Baird

Robert W. Baird

$396→$336

Hold

-11.42%

Downside

Downgraded

04/14/25

HCA Healthcare downgraded to Neutral from Outperform at BairdHCA Healthcare downgraded to Neutral from Outperform at Baird

Jason CassorlaGuggenheim

Guggenheim

―

Hold

―

Initiated

04/08/25

Guggenheim starts HCA Healthcare Inc (HCA) at NeutralGuggenheim analyst Jason Cassorla initiates coverage on HCA Healthcare Inc (NYSE: HCA) with a Neutral rating.

Ann HynesMizuho Securities

Mizuho Securities

$425

Buy

12.05%

Upside

Reiterated

02/27/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering HCA Healthcare

1 Month

xxx

Success Rate

25/36 ratings generated profit

Average Return

+4.36%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 69.44% of your transactions generating a profit, with an average return of +4.36% per trade.

3 Months

xxx

Success Rate

27/37 ratings generated profit

Average Return

+8.05%

reiterated a xxx

rating 5 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 72.97% of your transactions generating a profit, with an average return of +8.05% per trade.

1 Year

Ben HendrixRBC Capital

Success Rate

18/20 ratings generated profit

Average Return

+25.28%

reiterated a buy rating 7 days ago

Copying Ben Hendrix's trades and holding each position for 1 Year would result in 90.00% of your transactions generating a profit, with an average return of +25.28% per trade.

2 Years

xxx

Success Rate

36/36 ratings generated profit

Average Return

+42.79%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +42.79% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HCA Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HCA has received 17 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. HCA average Analyst price target in the past 3 months is 392.18.

Each month's total comprises the sum of three months' worth of ratings.

HCA Financial Forecast

HCA Earnings Forecast

Next quarter’s earnings estimate for HCA is $6.26 with a range of $5.60 to $6.59. The previous quarter’s EPS was $6.45. HCA beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.16% of the time in the same period. In the last calendar year HCA has Outperformed its overall industry.

HCA Sales Forecast

Next quarter’s sales forecast for HCA is $18.49B with a range of $18.16B to $18.85B. The previous quarter’s sales results were $18.32B. HCA beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.46% of the time in the same period. In the last calendar year HCA has Outperformed its overall industry.

HCA Stock Forecast FAQ

What is HCA’s average 12-month price target, according to analysts?

Based on analyst ratings, Hca Healthcare’s 12-month average price target is 392.18.

What is HCA’s upside potential, based on the analysts’ average price target?

Hca Healthcare has 3.40% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HCA a Buy, Sell or Hold?

Hca Healthcare has a consensus rating of Moderate Buy which is based on 8 buy ratings, 5 hold ratings and 0 sell ratings.

What is Hca Healthcare’s price target?

The average price target for Hca Healthcare is 392.18. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $444.00 ,the lowest forecast is $336.00. The average price target represents 3.40% Increase from the current price of $379.3.

What do analysts say about Hca Healthcare?

Hca Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of HCA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Analyst Ratings

HCA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering HCA Healthcare

HCA Analyst Recommendation Trends

HCA Financial Forecast

HCA Earnings Forecast

HCA Sales Forecast

HCA Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts